Viewing Study NCT06431620


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2025-12-26 @ 3:17 AM
Study NCT ID: NCT06431620
Status: RECRUITING
Last Update Posted: 2024-05-28
First Post: 2024-05-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer
Sponsor: Nanjing First Hospital, Nanjing Medical University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-06-30
Start Date Type: ESTIMATED
Primary Completion Date: 2026-05-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-22
First Submit QC Date: None
Study First Post Date: 2024-05-28
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-27
Last Update Post Date: 2024-05-28
Last Update Post Date Type: ACTUAL